---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-228399"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T00:50:13.375232+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vor Bio appoints Han Choi as CFO, effective Sept 30, 2024

## Summary
- Han Choi, M.D., LL.M., named CFO; previously Principal at Oracle Investment Management for over 20 years.
- Base salary of $464,000 per year and target annual bonus of 40% of base salary.
- Granted stock option for 400,000 shares, vesting over 4 years (1/4 after 1 year, then monthly).
- Choi brings experience in healthcare investment, business development, and capital markets strategy.

## SEC filing metadata
- accession: 0001193125-24-228399
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312524228399/0001193125-24-228399-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312524228399/d829992d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-228399
- JSON: https://secwatch.observer/filing/0001193125-24-228399.json
- Plain text: https://secwatch.observer/filing/0001193125-24-228399.txt

## Key facts
- Executive change
  Han Choi was appointed as Chief Financial Officer at Vor Biopharma Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On September 30, 2024, Vor Biopharma Inc. (the “Company”) announced that the board of directors (the “Board”) has appointed Han Choi, M.D., LL.M., as Chief Financial Officer of the Company, effective as of September 30, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1817229/000119312524228399/0001193125-24-228399-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
